{"id":"timebutine","rwe":[],"tags":[],"trials":[],"_chembl":null,"aliases":["Polybutin"],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Timebutine","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:29:50.375015+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:29:58.038882+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Timebutine","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:29:58.818846+00:00"}},"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"_scrapedAt":"2026-03-28T00:12:45.300Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:30:01.229415+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT01507922","phase":"PHASE4","title":"Comparative Efficacy and Safety of Fenoverine","status":"COMPLETED","sponsor":"Bukwang Pharmaceutical","startDate":"2011-12","conditions":"Irritable Bowel Syndrome","enrollment":186}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"HYPOGAMMAGLOBULINAEMIA"},{"count":1,"reaction":"NEUTROPENIA"},{"count":1,"reaction":"OPTIC NEURITIS RETROBULBAR"},{"count":1,"reaction":"OPTIC NEUROPATHY"},{"count":1,"reaction":"PAPILLOEDEMA"},{"count":1,"reaction":"SCOTOMA"},{"count":1,"reaction":"VISUAL ACUITY REDUCED"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":0,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Timebutine","genericName":"Timebutine","companyName":"Bukwang Pharmaceutical","companyId":"bukwang-pharmaceutical","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:30:01.229415+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}